Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abbott HCV EIA 2nd generation: a new screening assay.

W Weise1, U Bäcker, S Seidl

  • 1Blood Transfusion Center, Munich, FRG.

Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid tests and transfusion safety in Niamey, Niger.

Medecine et sante tropicales·2017
Same author

Knowledge, attitudes and clinical practice of blood products prescribers in Niamey.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2016
Same author

Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Bacterial contamination in platelet concentrates.

Vox sanguinis·2014
Same author

Scanning electron microscopy and epifluorescence investigation of bacterial colonization of marine sand sediments.

Microbial ecology·2013
Same author

[Seroprevalence of infectious markers among blood donors in Niamey (Niger)].

Revue d'epidemiologie et de sante publique·2013

A new hepatitis C virus antibody test (EIA-2) shows improved detection rates in patients and lower false positives in blood donors compared to older tests. This enhanced specificity aids in more accurate hepatitis C virus diagnosis.

Area of Science:

  • Virology
  • Immunology
  • Diagnostic Assays

Background:

  • Hepatitis C virus (HCV) infection diagnosis relies on antibody detection.
  • First-generation enzyme immunoassays (EIA-1) detect antibodies to limited HCV antigens.
  • Improved diagnostic tools are needed for accurate and efficient HCV screening.

Purpose of the Study:

  • To compare the performance of a second-generation enzyme immunoassay (EIA-2) with a first-generation test (EIA-1).
  • To evaluate the diagnostic accuracy of EIA-2 in detecting HCV antibodies.
  • To assess the specificity of EIA-2 in volunteer blood donors.

Main Methods:

  • Enzyme immunoassay (EIA) techniques were employed.
  • EIA-2 utilizes antibodies against both structural and nonstructural HCV domains.

Related Experiment Videos

  • EIA-1 detects antibodies against a single nonstructural antigen (c100).

    • Main Results:

    • EIA-2 demonstrated higher detection rates in high-risk and patient populations.
    • EIA-2 exhibited lower repeat reactive rates among volunteer blood donors.
    • The research test systems indicated an increase in apparent specificity for EIA-2.

    Conclusions:

    • EIA-2 offers superior performance over EIA-1 for hepatitis C virus antibody detection.
    • The enhanced specificity of EIA-2 reduces false positives in blood donor screening.
    • EIA-2 represents a significant advancement in HCV diagnostic capabilities.